SOPHiA GENETICS (SOPH) Short Interest Ratio & Short Volume $3.00 -0.29 (-8.81%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$3.26 +0.26 (+8.67%) As of 04/3/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOPHiA GENETICS Short Interest DataSOPHiA GENETICS (SOPH) has a short interest of 48,500 shares, representing 0.09% of the float (the number of shares available for trading by the public). This marks a -21.52% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 68,627 shares to cover all short positions.Current Short Interest48,500 sharesPrevious Short Interest61,800 sharesChange Vs. Previous Month-21.52%Dollar Volume Sold Short$156,170.00Short Interest Ratio0.6 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares66,687,000 sharesFloat Size52,290,000 sharesShort Percent of Float0.09%Today's Trading Volume29,300 sharesAverage Trading Volume68,627 sharesToday's Volume Vs. Average43% Short Selling SOPHiA GENETICS? Sign up to receive the latest short interest report for SOPHiA GENETICS and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSOPH Short Interest Over TimeSOPH Days to Cover Over TimeSOPH Percentage of Float Shorted Over Time Remove Ads SOPHiA GENETICS Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202548,500 shares $156,170.00 -21.5%0.1%0.6 $3.22 2/28/202561,800 shares $226,806.00 +64.4%0.1%0.8 $3.67 2/15/202537,600 shares $150,776.00 +89.9%0.1%0.5 $4.01 1/31/202519,800 shares $69,300.00 -34.0%0.0%0.4 $3.50 1/15/202530,000 shares $95,400.00 -4.5%0.1%0.7 $3.18 12/31/202431,400 shares $96,398.00 -15.1%0.1%1.2 $3.07 12/15/202437,000 shares $121,360.00 +38.6%0.1%1.5 $3.28 11/30/202426,700 shares $91,047.00 -52.7%0.1%1 $3.41 11/15/202456,500 shares $199,445.00 +134.4%0.1%1.9 $3.53 10/31/202424,100 shares $86,278.00 +66.2%0.1%0.6 $3.58 Get the Latest News and Ratings for SOPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SOPHiA GENETICS and its competitors with MarketBeat's FREE daily newsletter. 10/15/202414,500 shares $50,170.00 -0.7%0.0%0.3 $3.46 9/30/202414,600 shares $53,290.00 -22.8%0.0%0.3 $3.65 9/15/202418,900 shares $75,789.00 -52.0%0.0%0.3 $4.01 8/31/202439,400 shares $151,296.00 +47.0%0.1%0.5 $3.84 8/15/202426,800 shares $89,512.00 -61.6%0.1%0.2 $3.34 7/31/202469,800 shares $307,120.00 -12.4%0.2%0.7 $4.40 7/15/202479,700 shares $366,620.00 -12.6%0.2%0.8 $4.60 6/30/202491,200 shares $417,696.00 +22.3%0.2%0.8 $4.58 6/15/202474,600 shares $360,318.00 +38.2%0.2%0.7 $4.83 5/31/202454,000 shares $269,460.00 +155.9%0.1%0.5 $4.99 5/15/202421,100 shares $97,904.00 -57.7%0.1%0.3 $4.64 4/30/202449,900 shares $254,490.00 +7.8%0.1%0.8 $5.10 4/15/202446,300 shares $225,018.00 -12.0%0.1%0.8 $4.86 3/31/202452,600 shares $259,318.00 +22.3%0.1%1 $4.93 3/15/202443,000 shares $191,780.00 -28.6%0.1%0.9 $4.46 2/29/202460,200 shares $301,000.00 -0.7%0.1%1.3 $5.00 2/15/202460,600 shares $285,426.00 -2.4%0.1%1.7 $4.71 1/31/202462,100 shares $285,039.00 +7.4%0.1%1.7 $4.59 1/15/202457,800 shares $302,294.00 +19.2%0.1%1.3 $5.23 12/31/202348,500 shares $228,435.00 -4.9%0.1%1.2 $4.71 12/15/202351,000 shares $223,380.00 +50.4%0.1%1.5 $4.38 11/30/202333,900 shares $136,278.00 +52.7%0.1%1.1 $4.02 11/15/202322,200 shares $86,802.00 -51.7%0.1%0.6 $3.91 10/31/202346,000 shares $169,740.00 +59.2%0.1%1 $3.69 10/15/202328,900 shares $89,879.00 -20.2%0.1%0.6 $3.11 9/30/202336,200 shares $92,129.00 +35.6%0.1%0.7 $2.55 9/15/202326,700 shares $64,347.00 -4.3%0.1%0.5 $2.41 8/31/202327,900 shares $68,076.00 +1.1%0.1%0.5 $2.44 8/15/202327,600 shares $80,040.00 +22.1%0.1%0.5 $2.90 7/31/202322,600 shares $85,880.00 -27.6%0.1%0.3 $3.80Trump’s betrayal exposed (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 7/15/202331,200 shares $142,896.00 -12.9%0.1%0.5 $4.58 6/30/202335,800 shares $160,384.00 -23.2%0.1%0.6 $4.48 6/15/202346,600 shares $192,458.00 -7.5%0.1%0.7 $4.13 5/31/202350,400 shares $234,864.00 -44.6%0.1%0.4 $4.66 5/15/202390,900 shares $405,414.00 -15.6%0.2%0.7 $4.46 4/30/2023107,700 shares $521,268.00 +5.1%0.2%1 $4.84 4/15/2023102,500 shares $447,925.00 -11.6%0.2%0.8 $4.37 3/31/2023116,000 shares $576,520.00 -74.2%0.3%0.9 $4.97 3/15/2023449,700 shares $2.19 million +1,207.3%1.0%3.5 $4.86 2/28/202334,400 shares $89,440.00 -17.7%0.1%0.4 $2.60 2/15/202341,800 shares $112,024.00 +7.5%0.1%0.6 $2.68 1/31/202338,900 shares $116,700.00 -31.5%0.1%0.5 $3.00 1/15/202356,800 shares $177,784.00 +3.5%0.1%0.6 $3.13 12/30/202254,900 shares $113,094.00 +43.7%0.1%0.7 $2.06 12/15/202238,200 shares $89,006.00 -34.5%0.1%0.5 $2.33 11/30/202258,300 shares $134,673.00 -3.0%0.1%0.6 $2.31 11/15/202260,100 shares $123,205.00 +4.0%0.1%0.6 $2.05 10/31/202257,800 shares $127,160.00 -25.3%0.1%0.6 $2.20 10/15/202277,400 shares $175,698.00 -18.2%0.2%0.8 $2.27 9/30/202294,600 shares $248,798.00 No Change0.2%1.1 $2.63 9/15/202294,600 shares $255,420.00 -32.1%0.2%1.1 $2.70 8/31/2022139,300 shares $458,297.00 +10.3%0.3%1.5 $3.29 8/15/2022126,300 shares $568,350.00 -23.8%0.3%1.4 $4.50 7/31/2022165,800 shares $572,010.00 -2.9%0.3%1.7 $3.45 7/15/2022170,700 shares $529,170.00 -6.6%0.4%1.7 $3.10 6/30/2022182,800 shares $661,736.00 -50.3%0.4%1.8 $3.62 6/15/2022367,600 shares $1.03 million -27.8%0.8%3.5 $2.80 5/31/2022509,000 shares $2.14 million -0.9%1.1%6 $4.20 5/15/2022513,500 shares $2.47 million -3.9%1.1%7.4 $4.81 4/30/2022534,100 shares $3.43 million -3.2%1.1%8.3 $6.43 4/15/2022552,000 shares $3.86 million -8.0%1.1%7.1 $7.00 3/31/2022600,000 shares $4.64 million -16.1%1.2%6.6 $7.73 3/15/2022715,300 shares $5.87 million -1.1%1.4%8.4 $8.21 2/28/2022723,000 shares $9.25 million +7.3%1.4%8.8 $12.80 2/15/2022673,900 shares $8.21 million -18.2%1.3%7.7 $12.18 1/31/2022823,900 shares $9.64 million +41.3%1.6%8.9 $11.70 1/15/2022582,900 shares $8.24 million +6.9%1.2%6.8 $14.13 12/31/2021545,400 shares $7.69 million +6.3%1.1%8.9 $14.10 12/15/2021512,900 shares $6.94 million -6.8%1.0%8.7 $13.54 11/30/2021550,400 shares $7.69 million +17.2%1.1%9.7 $13.98 11/15/2021469,700 shares $7.42 million +3.8%0.9%8.1 $15.80 10/29/2021452,600 shares $6.42 million -1.3%0.9%6.9 $14.19 10/15/2021458,600 shares $7.38 million +0.6%0.9%4.5 $16.10 9/30/2021456,000 shares $7.99 million +2.7%0.9%2.8 $17.53 9/15/2021444,000 shares $7.21 million -0.3%0.9%2.3 $16.23 8/31/2021445,400 shares $8.81 million +85.1%0.9%1.9 $19.77 8/13/2021240,600 shares $4.33 million No Change0.5%0.7 $18.00 SOPH Short Interest - Frequently Asked Questions What is SOPHiA GENETICS's current short interest? Short interest is the volume of SOPHiA GENETICS shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 48,500 shares of SOPH short. 0.09% of SOPHiA GENETICS's shares are currently sold short. Learn More on SOPHiA GENETICS's current short interest. What is a good short interest ratio for SOPHiA GENETICS? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SOPH shares currently have a short interest ratio of 1.0. Learn More on SOPHiA GENETICS's short interest ratio. Which institutional investors are shorting SOPHiA GENETICS? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of SOPHiA GENETICS: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for SOPHiA GENETICS? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.09% of SOPHiA GENETICS's floating shares are currently sold short. Is SOPHiA GENETICS's short interest increasing or decreasing? SOPHiA GENETICS saw a decline in short interest during the month of March. As of March 15th, there was short interest totaling 48,500 shares, a decline of 21.5% from the previous total of 61,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is SOPHiA GENETICS's float size? SOPHiA GENETICS currently has issued a total of 66,687,000 shares. Some of SOPHiA GENETICS's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. SOPHiA GENETICS currently has a public float of 52,290,000 shares. How does SOPHiA GENETICS's short interest compare to its competitors? 0.09% of SOPHiA GENETICS's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to SOPHiA GENETICS: Phibro Animal Health Co. (3.60%), Xeris Biopharma Holdings, Inc. (7.88%), Oculis Holding AG (0.11%), Arcus Biosciences, Inc. (11.43%), Pharvaris (3.35%), Day One Biopharmaceuticals, Inc. (22.91%), Avid Bioservices, Inc. (18.17%), Chimerix, Inc. (4.30%), Evolus, Inc. (11.86%), Praxis Precision Medicines, Inc. (10.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short SOPHiA GENETICS stock? Short selling SOPH is an investing strategy that aims to generate trading profit from SOPHiA GENETICS as its price is falling. SOPH shares are trading down $0.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against SOPHiA GENETICS? A short squeeze for SOPHiA GENETICS occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SOPH, which in turn drives the price of the stock up even further. How often is SOPHiA GENETICS's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SOPH, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies PAHC Short Interest Data XERS Short Interest Data OCS Short Interest Data RCUS Short Interest Data PHVS Short Interest Data DAWN Short Interest Data CDMO Short Interest Data CMRX Short Interest Data EOLS Short Interest Data PRAX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SOPH) was last updated on 4/4/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SOPHiA GENETICS SA Please log in to your account or sign up in order to add this asset to your watchlist. Share SOPHiA GENETICS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
